Research-Grade Levofloxacin Overview
LQuin 750 mg Cipla is a pharmaceutical-grade antibiotic preparation containing levofloxacin, a third-generation fluoroquinolone compound extensively studied in antimicrobial research. Laboratory investigators at Stroid UK Shop examine this broad-spectrum agent for its unique mechanism of bacterial DNA disruption and resistance pattern studies.
Each tablet delivers precisely 750mg of pharmaceutical-standard levofloxacin, manufactured under strict quality controls by Cipla pharmaceuticals. Research facilities investigating fluoroquinolone pharmacology utilise this compound to study bacterial topoisomerase II and IV enzyme interactions, biofilm formation inhibition, and comparative antimicrobial spectrum analysis across gram-positive and gram-negative bacterial cultures.
Laboratory Research Applications
Academic researchers investigate levofloxacin’s molecular interactions in controlled laboratory environments. Microbiological studies examine this compound’s efficacy against respiratory pathogens, urogenital bacteria, and resistant bacterial strains in standardised culture media. Pharmaceutical laboratories analyse its pharmacokinetic properties, including tissue penetration profiles and elimination pathways in validated research models.
Comparative antimicrobial studies frequently examine levofloxacin alongside other fluoroquinolone antibiotics to evaluate relative potency and spectrum differences. Research teams also investigate synergistic effects when combined with beta-lactam antibiotics or other antimicrobial agents in laboratory culture systems.
Product Specifications
| Parameter | Value |
|---|---|
| Active Compound | Levofloxacin |
| Strength | 750mg per tablet |
| Manufacturer | Cipla Pharmaceuticals |
| CAS Number | 100986-85-4 |
| Molecular Formula | C₁₈H₂₀FN₃O₄ |
| Molecular Weight | 361.37 g/mol |
Unlike research compounds in our SARMs collection or peptide range, this antibiotic requires specific storage conditions and handling protocols. Store tablets in original packaging at room temperature, protected from moisture and light exposure.
Research Compliance Statement
LQuin 750 mg tablets are supplied exclusively for in-vitro laboratory research and analytical applications. This pharmaceutical preparation is intended for qualified research institutions conducting antimicrobial studies, bacterial culture research, or pharmaceutical analysis. Not approved for human consumption, clinical application, or therapeutic use. Researchers must follow institutional biosafety protocols when handling antimicrobial compounds and bacterial cultures. All laboratory studies should comply with relevant antimicrobial research guidelines and institutional ethics requirements.
